These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 6514931

  • 1. Behavioral effects of peripheral administration of arginine vasopressin: a review of our search for a mode of action and a hypothesis.
    Le Moal M, Dantzer R, Mormède P, Baduel A, Lebrun C, Ettenberg A, van der Kooy D, Wenger J, Deyo S, Koob GF.
    Psychoneuroendocrinology; 1984; 9(4):319-41. PubMed ID: 6514931
    [Abstract] [Full Text] [Related]

  • 2. Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory?
    Ettenberg A, van der Kooy D, Le Moal M, Koob GF, Bloom FE.
    Behav Brain Res; 1983 Mar; 7(3):331-50. PubMed ID: 6838716
    [Abstract] [Full Text] [Related]

  • 3. Vasopressin antagonists block peripheral as well as central vasopressin receptors.
    De Wied D, Gaffori O, Van Ree JM, De Jong W.
    Pharmacol Biochem Behav; 1984 Sep; 21(3):393-400. PubMed ID: 6093152
    [Abstract] [Full Text] [Related]

  • 4. Central target for the behavioural effects of vasopressin neuropeptides.
    de Wied D, Gaffori O, van Ree JM, de Jong W.
    Nature; 1984 Sep; 308(5956):276-8. PubMed ID: 6322010
    [Abstract] [Full Text] [Related]

  • 5. Vasopressin pressor antagonist injected centrally reverses behavioral effects of peripheral injection of vasopressin, but only at doses that reverse increase in blood pressure.
    Lebrun C, Le Moal M, Koob GF, Bloom FE.
    Regul Pept; 1985 Jun; 11(2):173-81. PubMed ID: 4035008
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Central injections of arginine vasopressin prolong extinction of active avoidance.
    Koob GF, Dantzer R, Bluthé RM, Lebrun C, Bloom FE, Le Moal M.
    Peptides; 1986 Jun; 7(2):213-8. PubMed ID: 3737445
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of peripherally administered arginine-vasopressin on learning, retention and forgetting in mice.
    Alescio-Lautier B, Soumireu-Mourat B.
    Behav Brain Res; 1990 Dec 14; 41(2):117-28. PubMed ID: 2288666
    [Abstract] [Full Text] [Related]

  • 11. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?
    de Wied D, Elands J, Kovács G.
    Proc Natl Acad Sci U S A; 1991 Feb 15; 88(4):1494-8. PubMed ID: 1847526
    [Abstract] [Full Text] [Related]

  • 12. Arginine vasopressin, stress, and memory.
    Koob GF, Lebrun C, Martinez JL, Dantzer R, Le Moal M, Bloom FE.
    Ann N Y Acad Sci; 1985 Feb 15; 444():194-202. PubMed ID: 3860087
    [Abstract] [Full Text] [Related]

  • 13. Effects of peripherally injected vasopressin and des-glycinamide vasopressin on the extinction of a spatial learning task in rats.
    Packard MG, Ettenberg A.
    Regul Pept; 1985 May 15; 11(1):51-63. PubMed ID: 4011956
    [Abstract] [Full Text] [Related]

  • 14. The action of centrally administered arginine vasopressin on blood pressure in the conscious rabbit.
    Martin SM, Malkinson TJ, Veale WL, Pittman QJ.
    Brain Res; 1985 Nov 25; 348(1):137-45. PubMed ID: 2933125
    [Abstract] [Full Text] [Related]

  • 15. [Effect of vasopressin on changes in the behavioral reactions of rats induced by psychotropic substances].
    Titov SA, Usenko AB, Ashmarin IP.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1989 Nov 25; 39(2):292-5. PubMed ID: 2750290
    [Abstract] [Full Text] [Related]

  • 16. Greater task difficulty amplifies the facilitatory effect of des-glycinamide arginine vasopressin on appetitively motivated learning.
    Messing RB, Sparber SB.
    Behav Neurosci; 1985 Dec 25; 99(6):1114-9. PubMed ID: 3843542
    [Abstract] [Full Text] [Related]

  • 17. Failure of vasopressin to enhance memory in a passive avoidance task in rats.
    Sahgal A, Keith AB, Wright C, Edwardson JA.
    Neurosci Lett; 1982 Jan 22; 28(1):87-92. PubMed ID: 7063145
    [Abstract] [Full Text] [Related]

  • 18. Centrally administered vasopressin antagonizes pentobarbital-induced narcosis and depression of hippocampal cholinergic activity.
    Horita A, Carino MA.
    Peptides; 1990 Jan 22; 11(5):1021-5. PubMed ID: 1980941
    [Abstract] [Full Text] [Related]

  • 19. Vasopressin: mechanism of central cardiovascular action in conscious rats.
    Rohmeiss P, Becker H, Dietrich R, Luft F, Unger T.
    J Cardiovasc Pharmacol; 1986 Jan 22; 8(4):689-96. PubMed ID: 2427805
    [Abstract] [Full Text] [Related]

  • 20. Antagonism of effects of vasopressin (AVP) on inhibitory avoidance by a vasopressin antagonist peptide [dPtyr(Me)AVP].
    LeBrun CJ, Rigter H, Martinez JL, Koob GF, Le Moal M, Bloom FE.
    Life Sci; 1984 Oct 01; 35(14):1505-12. PubMed ID: 6482669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.